Swiss pharmaceutical giant Novartis on Monday reported positive interim Phase III results for a new drug being studied to treat a rare kidney disease.
from Medical Xpress - latest medical and health news stories https://ift.tt/tg98DqR
Novartis says positive interim results on rare kidney disease drug
Posted by belhaouari bekhedda
Always On Time With Health News 24/7